From the editors – Page 18
-
OpinionThe kids aren’t alright
Making it more attractive for companies to develop paediatric drugs has the potential to improve everyone’s lives
-
OpinionA farewell to chemical arms
As chemical weapons stockpiles dwindle, international efforts must guard against renewed arsenals, says Mark Peplow
-
-
Opinion
The judgement of Paris
Our environmental ambitions are only as good as the companies we keep
-
OpinionHow the leopard got its spots
Alan Turing once looked to chemistry to suggest how patterns form
-
OpinionCount your blessings
With major funding cuts averted, UK chemists prepare to take on some of the world’s biggest challenges
-
OpinionThe periodic table name game
Proposed new rules on how elements are named save confusion but sacrifice romance, argues Philip Ball
-
OpinionScratching chiral surfaces
Heterogeneous asymmetric catalysis beyond hydrogenation is tricky, says Karl Collins
-
-
-
OpinionEmerging from Babel
Will English ever lose its place as the lingua franca of chemistry, asks Derek Lowe
-
Opinion
Toeing the advertising line
Companies have to tread a little carefully when it comes to advertising prescription drugs
-
Opinion
Chop and change
The UK research landscape is in a state of flux and decisions made now will dictate its direction for many years
-
OpinionFoaming at the reactor mouth
Turning a 1000 gallon reactor into a giant bubble bath is far from soothing, says Chemjobber
-
-
-
